Skip to content
FDAMedicines

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels

FDA recall n-greenwich-rx-issues-voluntary-nationwide-recall-compounded-glutathione-due-eleva ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Potential elevated endotoxin levels
Text from FDA, unedited.

The recalled product

IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.
Text from FDA, unedited.

Company announcement, as FDA publishes it

IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx , a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.

Risk Statement : There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. To date, Greenwich Rx has received two reports involving patients who received emergency department care following intravenous (IV) administration of a glutathione product that was not formulated for IV use.

Glutathione is a naturally occurring antioxidant that helps protect cells from oxidative stress. The voluntary recall affects the following lots of compounded glutathione 200 mg/mL dispensed in 10mL multidose vials and intended for subcutaneous injection:

The glutathione was distributed to patients nationwide between June 26, 2026, and September 21, 2026. Refer to the photo of the product label below for the location of lot number and beyond use date.

Greenwich Rx is notifying customers of this voluntary recall by mail. Customers who received glutathione from one of the recalled lots should stop using the product and follow the disposal instructions provided in the recall notification. Patients who believe they have experienced a health issue that may be related to the product should contact their healthcare provider.

Customers can direct questions regarding this recall to Sedgwick at (866) 552-4916 or GreenwichRx7542@sedgwick.com Monday through Friday between 8:00 AM to 5:00 PM Eastern Time.

Adverse reactions or quality problems experienced with the use of this product may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online : www.fda.gov/medwatch/report.htm

Regular Mail or Fax : Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Text from FDA (the company’s words), unedited.
  • Glutathione Injection 10mL

    Lot or code
    Strength: 200 mg/mL; Lot Number: 0060-062426-1; Beyond Use Date: 10/02/2026
  • 0060-062726-1

    Lot or code
    Strength: 10/05/2026
  • 0060-070926-1

    Lot or code
    Strength: 10/17/2026
  • 0060-071426-1

    Lot or code
    Strength: 10/22/2026
  • 0060-071426-2

    Lot or code
    Strength: 10/22/2026
  • 0060-072026-1

    Lot or code
    Strength: 10/28/2026
  • 0060-072726-1

    Lot or code
    Strength: 11/04/2026
  • 0060-072926-1

    Lot or code
    Strength: 11/06/2026
  • 0060-073126-1

    Lot or code
    Strength: 11/08/2026
  • 0060-080426-1

    Lot or code
    Strength: 11/12/2026
  • 0060-080526-1

    Lot or code
    Strength: 11/13/2026
  • 0060-081826-1

    Lot or code
    Strength: 11/26/2026

Source

Issued by
U.S. Food and Drug Administration
Firm
Greenwich Rx (other notices of this firm)

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: Greenwich Rx, Month: October 2026, Week 2026-W40. Browse more medicines recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Potential elevated endotoxin levels”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published this company announcement on October 1, 2026.

Other notices of Greenwich Rx